| Not Yet Recruiting | GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Dise NCT06546384 | Insel Gruppe AG, University Hospital Bern | N/A |
| Not Yet Recruiting | Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD) NCT07530419 | Seoul National University Hospital | — |
| Recruiting | Siemens Biomarker Multi-modality NCT07495332 | Duke University | N/A |
| Not Yet Recruiting | Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver Disea NCT07399600 | The Affiliated Hospital of Hangzhou Normal University | N/A |
| Recruiting | Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease NCT07242222 | Tanta University | Phase 1 / Phase 2 |
| Recruiting | Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease NCT07238985 | Tanta University | Phase 1 / Phase 2 |
| Recruiting | Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patient NCT06661655 | E-Scopics | N/A |
| Recruiting | Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly NCT07068191 | Phenomen Pharma | N/A |
| Completed | Effects of Short-Term Resistance Training on Diaphragm Thickness, Hepatic Fat Density, and Quality of Life in NCT07449767 | Gümüşhane Universıty | N/A |
| Completed | Effect of Inspiratory Muscle Training on Diaphragm Muscle Thickness, Fatty Liver Density and Aerobic Capacity NCT07193082 | Gümüşhane Universıty | N/A |
| Not Yet Recruiting | Effects of Compound Probiotics-Polygonatum Sibiricum on Liver Health and Metabolism in Middle-aged and Elderly NCT06873412 | Wecare Probiotics Co., Ltd. | N/A |
| Recruiting | Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes NCT06989723 | Seoul National University Bundang Hospital | Phase 4 |
| Not Yet Recruiting | Burden Fatty Liver Among Acute Ischemic Cerebral Stroke Patients NCT06628700 | Assiut University | — |
| Not Yet Recruiting | Perirenal Fats of Chronic Kidney Disease in Patients With Fatty Liver Disease. NCT06433388 | Assiut University | — |
| Not Yet Recruiting | Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes NCT06456970 | Assiut University | — |
| Recruiting | Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB) NCT06599918 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Phase 2 |
| Recruiting | Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter NCT06203548 | Chinese University of Hong Kong | N/A |
| Unknown | Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines NCT06257732 | Yeditepe University | N/A |
| Withdrawn | Fatty Liver Imaging Project ( FLIP ) Patient Pilot Study NCT03914482 | Aaron Fenster | N/A |
| Unknown | Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MA NCT05966025 | October 6 University | Phase 2 |
| Withdrawn | Assessment of Fatty Liver With Thermo-acoustic Device NCT04302051 | Medical College of Wisconsin | — |
| Recruiting | Effect of CoQ10 on the Outcome of MAFLD Patients NCT05984745 | Ain Shams University | Phase 2 |
| Active Not Recruiting | A Nutrigenetic Intervention in MASLD NCT06220695 | Maastricht University | N/A |
| Unknown | Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in NCT06051669 | New Discovery LLC | — |
| Active Not Recruiting | Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis NCT05979779 | Rivus Pharmaceuticals, Inc. | Phase 2 |
| Recruiting | Cardiac Dysfunction in Patients with Fatty Liver Disease NCT06386094 | Post Graduate Institute of Medical Education and Research, Chandigarh | — |
| Completed | Conditionally Increased Output (CIO) Enhanced Ultrasound System NCT05792423 | Massachusetts General Hospital | N/A |
| Recruiting | Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population NCT06225193 | Methodist Health System | — |
| Active Not Recruiting | Quantification of Hepatic Steatosis With Different Ultrasound Frequency NCT05855239 | Jong Keon Jang | — |
| Withdrawn | Diabetes Prevention and Education NCT05769127 | University of Maryland, Baltimore | N/A |
| Unknown | Body Composition and Fatty Liver Disease NCT05695118 | Seoul National University Hospital | N/A |
| Completed | Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study) NCT05804422 | Bogomolets National Medical University | N/A |
| Unknown | Night Hyperglycemia and Fatty Liver in Type 1 Diabetes NCT05933018 | HaEmek Medical Center, Israel | N/A |
| Unknown | A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer NCT05719480 | Nanfang Hospital, Southern Medical University | — |
| Unknown | Liver Enzymes and Metabolic Risk Factors Response to Laser Acupuncture Versus Cupping Therapy in Fatty Liver NCT05623930 | Cairo University | N/A |
| Completed | Efficacy of the echOpen Device to Detect Pyelocaliceal Dilation and Hepatic Steatosis NCT05280145 | Assistance Publique - Hôpitaux de Paris | N/A |
| Unknown | Prevalence of Non-alcoholic Fatty Liver Disease Among Non-obese Obstructive Sleep Apnea by Using Transient Ela NCT05351515 | Chinese University of Hong Kong | — |
| Recruiting | Early Tracking of Childhood Health Determinants (ETCHED) Study NCT03481829 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Ultrasound Assessment of Atherosclerotic Plaque Burden and Cardiovascular Risk: A 10-Year Prospective Study NCT06933745 | University Hospital, Akershus | — |
| Completed | Identification and Characterization of NAFLD in Turkey NCT05194553 | Maastricht University | — |
| Recruiting | Intermittent Fasting for NAFLD in Adults NCT04899102 | Massachusetts General Hospital | N/A |
| Recruiting | Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM o NCT03851627 | Alexandra Kautzky-Willer | Phase 4 |
| Terminated | A Study of JNJ-75220795 in Japanese Participants NCT05039710 | Janssen Pharmaceutical K.K. | Phase 1 |
| Unknown | Impact of Time-restricted Feeding in NAFLD NCT05220956 | Johannes Gutenberg University Mainz | N/A |
| Completed | Metabolic Effects of Plant-based Diet NCT05351853 | Koç University | N/A |
| Unknown | Lifestyle Modification in Psoriatic Patients With Fatty Liver NCT05125757 | Cairo University | N/A |
| Completed | Effects of Online App Weight Loss Programs on Liver Health in Obese Adults NCT05015491 | Noom Inc. | N/A |
| Unknown | Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping NCT04971434 | Cairo University | N/A |
| Unknown | A Single Center, Randomized, Open Label, Parallel Group, Phase 3 Study to Evaluate the Efficacy of Dapaglifloz NCT05308160 | National Taiwan University Hospital | Phase 3 |
| Completed | Low-Calorie Diet in People With Prediabetes/Metabolic Syndrome NCT04786418 | University of Liverpool | N/A |
| Completed | Limonene on Regulating Metabolism-related Fatty Liver Disease (MAFLD) and Analysis of TCM Constitution NCT04853082 | Hongsheng Tan | EARLY_Phase 1 |
| Unknown | Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH NCT04702490 | Metacrine, Inc. | Phase 2 |
| Unknown | Low GI Diet Effects on Non-Alcoholic Fatty Liver Disease NCT04415632 | University of Nottingham | N/A |
| Unknown | The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steat NCT05370053 | University of Kansas Medical Center | N/A |
| Unknown | Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver Disease NCT04463667 | National Taiwan University Hospital | N/A |
| Completed | Quantitative US for Evaluation of Hepatic Steatosis in NAFLD NCT04462562 | Seoul National University Hospital | N/A |
| Withdrawn | A Pilot Study to Explore the Role of Gut Flora in Fatty Liver NCT04160949 | ProgenaBiome | — |
| Completed | Effect of Focused Ultrasound on Abdominal and Intrahepatic Fat in Patients With Non-alcoholic Fatty Liver Dise NCT04161703 | Cairo University | N/A |
| Recruiting | Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disea NCT04873258 | Richmond Research Institute | — |
| Unknown | Omega-3 Supplementation for LIver VolumE Reduction Study (OLIVER) Study NCT03972319 | Khoo Teck Puat Hospital | EARLY_Phase 1 |
| Recruiting | PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies NCT04371042 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Completed | Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM NCT02289235 | Shiraz University of Medical Sciences | EARLY_Phase 1 |
| Unknown | A Pathophysiological Study of the Postprandial Human Liver (PLS) NCT03849235 | Copenhagen University Hospital, Hvidovre | — |
| Completed | Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver NCT04281121 | Ain Shams University | N/A |
| Completed | Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascu NCT03375788 | Massachusetts General Hospital | Phase 2 |
| Completed | Antidiabetic Drugs for Steatotic Liver Disease NCT03646292 | Yonsei University | Phase 4 |
| Completed | An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis NCT03656068 | Pinnacle Clinical Research, PLLC | Phase 2 |
| Completed | A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Popula NCT03726827 | Fatty liver Foundation | — |
| Active Not Recruiting | The Effects of Low Carbohydrate Diet on Liver Fat Content and Mitochondrial Fluxes NCT03737071 | Helsinki University Central Hospital | N/A |
| Completed | Diabetes, Exercise and Liver Fat (DELIVER) NCT04004273 | James King | N/A |
| Completed | Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway NCT03480594 | University of Texas Southwestern Medical Center | — |
| Unknown | Liver Steatosis and Stiffness in HIV NCT03599882 | Chang Gung Memorial Hospital | — |
| Withdrawn | Prediction of Donor Liver Adipose Content by Magnetic Resonance Imaging NCT02873507 | Vanderbilt University Medical Center | N/A |
| Completed | Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers NCT03513523 | Elysium Health | N/A |
| Completed | Study of Gemcabene in Adults With FPLD NCT03508687 | Elif Oral | Phase 1 / Phase 2 |
| Completed | Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir NCT03374358 | Helsinki University Central Hospital | Phase 4 |
| Unknown | Inflammation and Steatosis: the Role of Alpha-defensin NCT03358420 | Hillel Yaffe Medical Center | — |
| Completed | Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet NCT03141008 | Virginia Commonwealth University | — |
| Completed | A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Au NCT03193177 | Tsinghua University | — |
| Completed | Alpha-Glutathione-S-Transferase (AlphaGST) and MARINA Index in Metabolic-Dysfunction-Associated-Steatotic-Live NCT05804955 | University of Campania Luigi Vanvitelli | — |
| Completed | The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Nonalcoholic Fatty Liver Disease NCT02983669 | Shiraz University of Medical Sciences | N/A |
| Completed | Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Ty NCT03233178 | LMC Diabetes & Endocrinology Ltd. | — |
| Completed | Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound Measurement NCT02784925 | Taipei Medical University WanFang Hospital | N/A |
| Unknown | Complex Imaging Assessment of Steatosis NCT02669641 | University of Medicine and Pharmacy Craiova | Phase 4 |
| Completed | Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease NCT02520609 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Effect of Probiotic and Smectite Gel on NAFLD NCT03614039 | Nazarii Kobyliak | N/A |
| Completed | Transforming Non-Invasive Liver Disease Detection by MRE: The Hepatogram NCT02565446 | Mayo Clinic | N/A |
| Completed | Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent NCT02660047 | Leiden University Medical Center | Phase 4 |
| Unknown | Fatty Liver Disease Collaborative Research in China NCT02391168 | Fatty Liver and Alcoholic Liver Disease Study Group, China | — |
| Completed | A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NAS NCT02279524 | Galmed Research and Development, Ltd. | Phase 2 |
| Completed | Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD) NCT02363309 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Pati NCT02210715 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 4 |
| Completed | Single-Cell and Spatial Transcriptomics Analysis of Steatotic Donor Liver Susceptibility to Post-Transplant In NCT07362745 | Xijing Hospital | — |
| Unknown | Metabolic Syndrome and Non-alcoholic Fatty Liver During Pregnancy NCT02276144 | Seoul National University Hospital | — |
| Completed | Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women NCT00862433 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 1 |
| Unknown | A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease NCT02265276 | Command Hospital, India | Phase 3 |
| Completed | Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults NCT02347007 | Columbia University | N/A |
| Completed | Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease NCT02860884 | Rennes University Hospital | — |
| Completed | Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic Syndrome NCT02358928 | University of Texas Southwestern Medical Center | N/A |
| Unknown | Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic Steat NCT02456766 | Wuxi Hisky Medical Technology Co Ltd | — |
| Completed | MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism NCT02102646 | Herlev Hospital | Phase 4 |
| Completed | Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients NCT01761318 | Leiden University Medical Center | Phase 4 |
| Completed | Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepat NCT01934777 | Bambino Gesù Hospital and Research Institute | Phase 3 |
| Recruiting | Blood Collection Biorepository for Liver Disease Research NCT03025074 | State University of New York at Buffalo | — |
| Completed | Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients NCT02009592 | Bezmialem Vakif University | N/A |
| Unknown | Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease NCT01720719 | Xin Gao | Phase 4 |
| Completed | Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E NCT01792115 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | The Effect of Pentoxifylline on Liver Function Tests in Fatty Liver Disease NCT02283710 | Tehran University of Medical Sciences | Phase 2 |
| Completed | Low Fat Vegan or American Heart Association Diets & Cardiovascular Risk in Obese 9-18 y.o. With Elevated Chole NCT01817491 | The Cleveland Clinic | N/A |
| Completed | Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity NCT02427087 | University of Sao Paulo General Hospital | N/A |
| Completed | Impact of Bariatric Surgery on the Evolution of Nonalcoholic Fatty Liver Disease: a Comparative Clinical Trial NCT02394353 | Ministry of Health, Brazil | Phase 1 |
| Completed | Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD NCT02031913 | Seoul National University Boramae Hospital | — |
| Unknown | An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasi NCT02174367 | King's College London | — |
| Completed | Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease NCT01766960 | University of North Carolina, Chapel Hill | Phase 1 |
| Unknown | Telomere Parameters in Patients With Nonalcoholic Fatty Liver NCT01694342 | Meir Medical Center | — |
| Completed | Genetic Variant in Apolipoprotein C3 Gene and Fatty Liver in Obese Children NCT01682655 | Far Eastern Memorial Hospital | — |
| Completed | The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease NCT01876108 | Tehran University of Medical Sciences | Phase 2 |
| Completed | Resveratrol in Patients With Non-alcoholic Fatty Liver Disease NCT01464801 | University of Aarhus | N/A |
| Terminated | Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver NCT01423630 | Region Skane | N/A |
| Completed | Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease NCT01284634 | GW Research Ltd | Phase 2 |
| Unknown | Multiparametric MR for Rapid Imaging Assessment of the Liver NCT01543646 | University of Oxford | — |
| Unknown | Clinical Study of Serum Fetuin A Level, Insulin Resistance and Hepatic Fat Content in Dialysis Patients NCT01457625 | Far Eastern Memorial Hospital | — |
| Completed | NAFLD: Independent Effects of Western Dietary Pattern Profile and Sedentary Life NCT02670590 | Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele | N/A |
| Completed | Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth NCT01725035 | Yale University | — |
| Completed | Liver Fat Quantification by Magnetic Resonance Imaging (MRI) - Prediction of Postoperative Complications NCT01234714 | University of Zurich | — |
| Completed | Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease NCT00949403 | Washington University School of Medicine | EARLY_Phase 1 |
| Completed | Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease NCT01147523 | Aristotle University Of Thessaloniki | Phase 2 |
| Completed | Omega 3 Supplementation in Fatty Liver NCT01992809 | University of Sao Paulo General Hospital | Phase 3 |
| Completed | Effect of Diet Composition on Liver Fat and Glucose Metabolism NCT00930371 | University of Washington | N/A |
| Terminated | Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) NCT00736385 | Duke University | Phase 4 |
| Terminated | Fatty Liver in Inflammatory Bowel Disease (IBD) Patients NCT00855907 | Tel-Aviv Sourasky Medical Center | — |
| Completed | Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) NCT00885313 | Bambino Gesù Hospital and Research Institute | Phase 1 / Phase 2 |
| Unknown | Visceral Abdominal Fat, Non Alcoholic Fatty Liver Diseases and Asymptomatic Coronary Atherosclerosis NCT01282892 | Ziv Hospital | — |
| Completed | Role of Dietary Fatty Acids in Fatty Liver and Insulin Resistance NCT01038102 | Uppsala University | N/A |
| Completed | Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease NCT00815009 | San Antonio Military Medical Center | N/A |
| Completed | A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH) NCT00799578 | Joel Lavine | Phase 1 / Phase 2 |
| Terminated | Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections NCT00742326 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 4 |
| Terminated | Study of Fish Oil to Reduce ALT Levels in Adolescents NCT00694746 | Boston University | Phase 1 |
| Completed | The Effect of Growth Hormone Replacement on Liver Fat NCT00774579 | Imperial College London | — |
| Terminated | An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Wi NCT00577148 | Sanofi | Phase 3 |
| Completed | Echocardiography, Adherence to Mediterranean Diet (AMDS) and Physical Exercise in Fatty Liver NCT02669316 | Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele | — |
| Terminated | An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Wi NCT00576667 | Sanofi | Phase 3 |
| Completed | MRI to Measure Liver Fat Content NCT00594412 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Completed | Tzu Chi Health Study (Diabetes and Cardiometabolic Health Components) NCT03204552 | Dalin Tzu Chi General Hospital | — |
| Terminated | Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver NCT00529204 | University of California, Davis | Phase 2 |
| Completed | Study of INT-747 in Patients With Diabetes and Presumed NAFLD NCT00501592 | Intercept Pharmaceuticals | Phase 2 |
| Unknown | Fatty Liver in Pregnancy NCT00471575 | Assaf-Harofeh Medical Center | — |
| Completed | Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH) NCT00681408 | University of Virginia | Phase 2 / Phase 3 |
| Completed | A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH) NCT00443079 | Heather Patton | Phase 2 |
| Completed | Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultra NCT01100398 | Brooke Army Medical Center | — |
| Completed | Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents Wit NCT00585299 | Yale University | N/A |
| Completed | Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipi NCT00476879 | University of Aarhus | N/A |
| Completed | Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver NCT00323414 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | Nonalcoholic Fatty Liver Disease in Taiwanese Children NCT00274183 | Far Eastern Memorial Hospital | — |
| Terminated | Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With F NCT00274495 | Beth Israel Medical Center | Phase 4 |
| Completed | Long-term Follow Up of Patients in the Birmingham and Lambeth Liver Evaluation Strategies (BALLETS) Study NCT04022681 | University of Warwick | — |
| Terminated | Insulin Resistance in Non-alcoholic Fatty Liver Disease NCT00252499 | US Department of Veterans Affairs | N/A |
| Terminated | Insulin Resistance in Non-alcoholic Fatty Liver Disease NCT01289639 | VA Office of Research and Development | N/A |
| Completed | Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC) NCT00063635 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Completed | Development of a Breath Test for Monitoring Patients With Liver Disease NCT00244569 | Virginia Commonwealth University | Phase 3 |
| Completed | Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasy NCT00207311 | Brooke Army Medical Center | Phase 4 |
| Terminated | The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics NCT00068094 | National Center for Complementary and Integrative Health (NCCIH) | Phase 1 / Phase 2 |
| Completed | Relation of Obesity With Frequency of Meals (MST 0557) NCT00229255 | Rockefeller University | N/A |
| Completed | Weight Management in Nonalcoholic Steatohepatitis NCT00266019 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Unknown | Metformin in Non-Alcoholic Fatty Liver Disease NCT00303537 | University Hospital, Aker | Phase 2 / Phase 3 |
| Terminated | The Effect of a Probiotic on Hepatic Steatosis NCT00099723 | VSL Pharmaceuticals | Phase 1 |
| Unknown | Non Alcoholic Fatty Liver Disease (NAFLD) in Hong Kong NCT00577044 | Hospital Authority, Hong Kong | — |
| Terminated | Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions NCT00152815 | Johane Allard | Phase 2 |
| Completed | Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH) NCT00160407 | St. Louis University | Phase 4 |
| Unknown | Observational Study of Early Metabolic and Vascular Changes in Obesity NCT00482924 | Medical University of Graz | — |
| Completed | Steatohepatitis in Chronic Hepatitis B NCT05317260 | Mahidol University | — |
| Completed | Treatment of Nonalcoholic Steatohepatitis With Pioglitazone NCT00013598 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition NCT00004697 | University of Texas | N/A |